What is the appropriate dosage of Mylanta (aluminum hydroxide, magnesium hydroxide, simethicone) for adults and children, and what are its contraindications?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Mylanta Dosing and Contraindications

For adults and children 12 years and older, the appropriate dose of Mylanta is 10-20 mL (1-2 doses) between meals and at bedtime, not exceeding 60 mL (6 doses) in 24 hours, and maximum dosage should not be used for more than 2 weeks. 1

Adult and Adolescent Dosing (≥12 years)

  • Standard dose: 10-20 mL per dose
  • Timing: Between meals, at bedtime, or as directed by physician
  • Maximum daily dose: 60 mL (6 doses) in any 24-hour period
  • Duration limit: Do not use maximum dosage for more than 2 weeks 1
  • Administration: Shake well before use; measure with provided dosing cup 1

Pediatric Dosing (<12 years)

Children under 12 years should not receive Mylanta without consulting a physician. 1 The FDA labeling explicitly states "ask a doctor" for this age group, indicating that pediatric dosing requires individualized medical assessment rather than over-the-counter use.

Contraindications and Precautions

While the provided FDA label does not explicitly list contraindications 1, important considerations based on the aluminum hydroxide/magnesium hydroxide/simethicone formulation include:

Key Safety Concerns:

  • Renal impairment: Aluminum-containing antacids require caution in patients with reduced kidney function due to potential aluminum accumulation
  • Drug interactions: Mylanta significantly reduces bioavailability of certain medications when co-administered:
    • Reduces ranitidine bioavailability by one-third 2
    • Decreases tebipenem pivoxil peak concentration by 22% 3
    • Lowers saxagliptin peak concentration by 26% 4

Clinical Efficacy Context:

Research demonstrates that this aluminum/magnesium hydroxide formulation effectively increases esophageal pH with faster onset than calcium carbonate antacids 5. The duration of action in the esophagus is approximately 82 minutes, with minimal gastric acid rebound compared to calcium-based alternatives 5.

Important Caveats:

  • Tamper evidence: Do not use if printed seal under cap is broken or missing 1
  • Alcohol content: Contains 0.2% alcohol 1
  • Pregnancy: While antacids are commonly used in pregnancy 6, specific medical guidance should be sought
  • Medication timing: Consider separating Mylanta administration from other oral medications by at least 1-2 hours to avoid absorption interference

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.